Es gab 50 kürzliche Insider-Transaktionen für CVRx, Inc. (CVRX), darunter 30 Käufe und 14 Verkäufe. Die gesamten Insider-Käufe beliefen sich auf $7.54M und die gesamten Insider-Verkäufe auf $1.01M.
Bedeutende Insider mit kürzlicher Aktivität umfassen Hykes Kevin, Oasheim Jared, Verrastro Paul. Insider-Transaktionen können Einblicke geben, wie die Unternehmensführung die Bewertung und Zukunftsaussichten der Aktie einschätzt.
Insider-Transaktionen — CVRX
| Datum |
Name |
Funktion |
Transaktionsart |
Aktien |
Ø Preis |
Wert |
Gehaltene Aktien |
| 2026-03-02 |
Hykes Kevin |
Pres & CEO |
Informierter Verkauf |
7,763 |
$7.90 |
$61.35K |
284,237 |
| 2026-03-02 |
Oasheim Jared |
Chief Financial Officer |
Informierter Verkauf |
1,744 |
$7.90 |
$13.78K |
96,703 |
| 2026-03-02 |
Verrastro Paul |
Chief Mktg & Strat Officer |
Informierter Verkauf |
1,284 |
$7.90 |
$10.15K |
60,551 |
| 2026-03-02 |
John Robert Allen |
Chief Revenue Officer |
Informierter Verkauf |
3,964 |
$7.90 |
$31.33K |
86,036 |
| 2026-03-02 |
Morrison Gregory |
Officer |
Unbekannt |
- |
- |
- |
- |
| 2026-03-02 |
Morrison Gregory |
Chief Human Resources Officer |
RSU-Zuteilung |
34,000 |
- |
- |
34,000 |
| 2026-03-02 |
Adamson Philip B. |
Chief Medical Officer |
Informierter Verkauf |
1,262 |
$7.90 |
$9.97K |
61,578 |
| 2026-02-27 |
Hykes Kevin |
Pres & CEO |
RSU-Zuteilung |
238,000 |
$8.16 |
$1.94M |
238,000 |
| 2026-02-27 |
Binkowski Brent |
Chief Operating Officer |
RSU-Zuteilung |
23,000 |
$8.16 |
$187.68K |
23,000 |
| 2026-02-27 |
Oasheim Jared |
Chief Financial Officer |
RSU-Zuteilung |
91,000 |
$8.16 |
$742.56K |
91,000 |
| 2026-02-27 |
Verrastro Paul |
Chief Mktg & Strat Officer |
RSU-Zuteilung |
45,000 |
- |
- |
61,835 |
| 2026-02-27 |
John Robert Allen |
Chief Revenue Officer |
RSU-Zuteilung |
52,000 |
$8.16 |
$424.32K |
52,000 |
| 2026-02-27 |
Adamson Philip B. |
Chief Medical Officer |
RSU-Zuteilung |
62,000 |
$8.16 |
$505.92K |
62,000 |
| 2026-02-20 |
Jain Mudit K. |
Director |
Informierter Kauf |
46,800 |
$6.36 |
$297.59K |
980,183 |
| 2026-02-18 |
Jain Mudit K. |
Director |
Informierter Kauf |
600 |
$4.64 |
$2.79K |
5,650 |
| 2025-11-26 |
Johnson & Johnson |
10 Percent Owner |
Informierter Verkauf |
6,337 |
$10.03 |
$63.56K |
4,024,861 |
| 2025-11-26 |
Johnson & Johnson |
10 Percent Owner |
Informierter Verkauf |
6,337 |
$10.03 |
$63.56K |
4,040,861 |
| 2025-11-25 |
Johnson & Johnson |
10 Percent Owner |
Informierter Verkauf |
16,000 |
$10.03 |
$160.48K |
4,031,198 |
| 2025-11-24 |
Johnson & Johnson |
10 Percent Owner |
Informierter Verkauf |
2,200 |
$10.06 |
$22.13K |
4,047,198 |
| 2025-11-21 |
Johnson & Johnson |
10 Percent Owner |
Informierter Verkauf |
500 |
$10.00 |
$5K |
4,049,398 |
| 2025-11-12 |
Johnson & Johnson |
10 Percent Owner |
Informierter Verkauf |
1,000 |
$10.00 |
$10K |
4,049,898 |
| 2025-11-07 |
Johnson & Johnson |
10 Percent Owner |
Informierter Verkauf |
200 |
$10.00 |
$2K |
4,050,898 |
| 2025-11-06 |
Johnson & Johnson |
10 Percent Owner |
Informierter Verkauf |
52,332 |
$10.21 |
$534.31K |
4,051,098 |
| 2025-08-11 |
Binkowski Brent |
Officer |
Unbekannt |
- |
- |
- |
- |
| 2025-08-11 |
Binkowski Brent |
Chief Operating Officer |
RSU-Zuteilung |
16,600 |
- |
- |
16,600 |
| 2025-06-03 |
Slattery Joseph P |
Director |
RSU-Zuteilung |
19,554 |
$6.76 |
$132.19K |
19,554 |
| 2025-06-03 |
Nielsen Kirk G. |
Director |
RSU-Zuteilung |
19,554 |
$6.76 |
$132.19K |
19,554 |
| 2025-06-03 |
Ballinger Kevin J. |
Director |
RSU-Zuteilung |
19,554 |
$6.76 |
$132.19K |
19,554 |
| 2025-06-03 |
Jain Mudit K. |
Director |
RSU-Zuteilung |
19,554 |
$6.76 |
$132.19K |
19,554 |
| 2025-06-03 |
Hill, Mitch C. |
Director |
RSU-Zuteilung |
19,554 |
$6.76 |
$132.19K |
19,554 |
| 2025-06-03 |
Shadan Martha |
Director |
RSU-Zuteilung |
19,554 |
$6.76 |
$132.19K |
19,554 |
| 2025-05-15 |
Nielsen Kirk G. |
Director |
Informierter Kauf |
10,966 |
$5.45 |
$59.8K |
1,910,134 |
| 2025-05-14 |
Nielsen Kirk G. |
Director |
Informierter Kauf |
61,200 |
$5.23 |
$320.36K |
1,899,168 |
| 2025-05-13 |
Jain Mudit K. |
Director |
Informierter Kauf |
150 |
$5.26 |
$789.00 |
5,050 |
| 2025-05-13 |
Nielsen Kirk G. |
Director |
Informierter Kauf |
101,413 |
$5.29 |
$536.31K |
1,837,968 |
| 2025-05-12 |
Hykes Kevin |
Pres & CEO |
Informierter Kauf |
5,000 |
$4.84 |
$24.2K |
133,000 |
| 2025-05-12 |
Jain Mudit K. |
Director |
Informierter Kauf |
1,500 |
$4.66 |
$6.99K |
4,900 |
| 2025-05-12 |
Nielsen Kirk G. |
Director |
Informierter Kauf |
25,200 |
$4.79 |
$120.67K |
1,736,555 |
| 2025-02-28 |
Hykes Kevin |
Pres & CEO |
RSU-Zuteilung |
98,000 |
- |
- |
128,000 |
| 2025-02-28 |
Oasheim Jared |
Chief Financial Officer |
RSU-Zuteilung |
33,000 |
$12.96 |
$427.68K |
33,000 |
| 2025-02-28 |
Verrastro Paul |
Chief Mktg & Strat Officer |
RSU-Zuteilung |
16,000 |
- |
- |
16,835 |
| 2025-02-28 |
John Robert Allen |
Chief Revenue Officer |
RSU-Zuteilung |
38,000 |
$12.96 |
$492.48K |
38,000 |
| 2025-02-28 |
Adamson Philip B. |
Chief Medical Officer |
RSU-Zuteilung |
20,000 |
- |
- |
20,000 |
| 2025-02-04 |
Adamson Philip B. |
Chief Medical Officer |
Unbekannt |
190,208 |
$7.82 |
$1.49M |
- |
| 2024-11-21 |
Verrastro Paul |
Chief Mktg & Strat Officer |
Schenkung (gegeben) |
1,040 |
- |
- |
835 |
| 2024-11-19 |
Verrastro Paul |
Chief Mktg & Strat Officer |
Informierter Verkauf |
1,430 |
$13.58 |
$19.42K |
1,875 |
| 2024-09-03 |
Ballinger Kevin J. |
Officer |
Unbekannt |
- |
- |
- |
- |
| 2024-09-03 |
Ballinger Kevin J. |
Director |
RSU-Zuteilung |
36,136 |
$9.05 |
$327.03K |
36,136 |
| 2024-09-03 |
Hill, Mitch C. |
Officer |
Unbekannt |
- |
- |
- |
- |
| 2024-09-03 |
Hill, Mitch C. |
Director |
RSU-Zuteilung |
36,136 |
$9.05 |
$327.03K |
36,136 |
■ Informativ — Transaktion am offenen Markt (bedeutendste)
■ Nicht-informativ (Kauf) — Vergütung, Optionsausübung, Wandlung
■ Nicht-informativ (Verkauf) — Quellensteuer, Verkauf bei Vesting
■ Neutral — Schenkung, Treuhand, Verfall
